Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2000 | 06-2000 | 03-2000 | 12-1999 | 09-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,380 | -7,580 | -3,270 | -27,030 | -23,910 |
| Depreciation Amortization | 1,310 | 730 | 350 | 1,610 | 1,130 |
| Other Working Capital | 3,860 | 320 | -530 | -1,000 | -1,090 |
| Other Operating Activity | 30,490 | 1,610 | 560 | 15,810 | 15,210 |
| Operating Cash Flow | $280 | $-4,920 | $-2,890 | $-10,610 | $-8,660 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -800 | -380 | -360 | -1,850 | -1,380 |
| Other Investing Activity | 1,230 | 340 | -550 | 6,900 | 6,380 |
| Investing Cash Flow | $430 | $-40 | $-910 | $5,050 | $5,000 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 34,010 | 28,800 | 29,040 | 7,790 | 6,760 |
| Financing Cash Flow | $34,010 | $28,800 | $29,040 | $7,790 | $6,760 |
| Beginning Cash Position | 4,100 | 4,100 | 4,100 | 1,870 | 1,870 |
| End Cash Position | 38,830 | 27,940 | 29,330 | 4,100 | 4,970 |
| Net Cash Flow | $34,730 | $23,840 | $25,230 | $2,230 | $3,100 |
| Free Cash Flow | |||||
| Operating Cash Flow | 280 | -4,920 | -2,890 | -10,610 | -8,660 |
| Free Cash Flow | 280 | -4,920 | -2,890 | -10,610 | -8,660 |